<DOC>
	<DOCNO>NCT01365416</DOCNO>
	<brief_summary>The prevalence morbid obesity ( BMI &gt; 40 kg/m2 ) increase rapidly UK , investigator lack coherent strategy detailed assessment treatment individual affect , high risk morbidity early mortality . The investigator already know 1 20 severely-obese individual simple genetic cause obesity ( usually inherit autosomal dominant pattern . Bariatric surgery effective treatment morbid obesity certain surgery result remission type 2 diabetes . However , patient fail achieve weight loss experience complication re-operations . The investigator unable predict outcome bariatric surgery particularly relation type 2 diabetes remission crucial assessment risk benefit balance wider future application surgery . The investigator want investigate mechanism underlie Type 2 diabetes remission bariatric surgery A ) examine effect Mendelian form obesity diabetes T2D remission , B ) study change expression profile pattern insulin-responsive tissue , C ) identify eQTLs , genetic variation affect T2D remission D ) study role epigenetic variation T2D remission .</brief_summary>
	<brief_title>Personalised Medicine Morbid Obesity</brief_title>
	<detailed_description>SUBJECTS SAMPLES Obese patient ( n=2000 ) present Obesity , Endocrine Medical Clinics Imperial College Healthcare NHS Trust recruit initial presentation service . The patient include study patient BMI &gt; 28 kg/m2 age 18-65 . Subjects undergo blood , saliva , urine faeces sample . Patients also ask consent muscle , liver , subcutaneous visceral fat tissue collect time surgery . If patient undergo re-operation blood sample , muscle , liver , subcutaneous visceral fat tissue need collect . Collections sample centre ( e.g Gothenburg ) may analyse similar way alongside sample specify . METHODS The investigator use method represent state-of-the-art time analysis . Current plan outline : Standard current method use extract DNA saliva blood patient screen monogenic obesity diabetes . RNA extract blood tissue perform genome-wide expression analysis . DNA use perform genome-wide target SNP genotyping identification eQTLs , genetic variation influence outcome bariatric surgery . DNA extract blood tissue use standard method perform epigenetic analysis . Patients ask bring early morning urine sample well faeces sample later metabonomic/ metagenomic analysis . Blood sample also use measure C-peptide , fast glucose insulin biomarkers become available . Subject 's weight take follow-up visit . Subjects also analyse range phenotype concerned obesity co-morbidity well psychological relate outcome . PROTOCOL First point contact ( group information session ) : 1 . Verbal introduction study 2 . Participant information sheet ( Appendix 2 ) 3 . Containers urine faeces sample hand patient 4 . 1 week follow-up telephone contact consent proceed onto first study visit Visit 1 : Screening visit ( pre-surgery assessment ( part routine visit ) ) : 1 . Further explanation study confirmation understand 2 . Signed consent form ( Appendix 3 ) 3 . Family history questionnaire 4 . Measurement height , weight , head circumference , foot hand size ( support Photographic documentation ) 5 . Psychological questionnaire ( complete patient prior first study visit upon initial referral obesity service audit purpose . Consent seek use first study visit ) 6 . Blood saliva 7 . Routine blood test measure C-peptide , fast glucose insulin 8 . Early morning urine faeces sample Visit 2 ( actual surgery ) : 1 . Blood , muscle- , liver- , subcutaneous- visceral fat tissue Visit 3 ( 2 day surgery ) : 1 . Blood 2 . Weight Visit 4 ( 10 day post-surgery ) : 1 . Blood 2 . Weight 3 . Urine Visit 5 ( 6 month post-surgery ) : 1 . Blood 2 . Weight 3 . Urine Visit 6 ( 12 month post-surgery - part routine follow-up visit ) : 1 Blood 2 Weight 3 Psychological questionnaire Visit 7 ( 18 month post -surgery ) : 1 . Early morning urine faeces sample 2 . Weight QUESTIONNAIRES Before 1st study visit 12 month post-surgery , subject complete follow questionnaire assess eat behaviour personality measure : 1 . Eating Disorder Examination Questionnaire ( EDEQ ) - identify number binge per 28 day ( Fairburn CG , Beglin S Int Jour . Eat Dis 16:363370 , 1994 ) ( Appendix 4 ) . 2 . Dutch Eating Behaviour Questionnaire ( DEBQ ) measure restraint , emotional external influence eat behaviour ( Wardle J Psychosom Res 31:1619 , 1987 ) ( Appendix 5 ) . 4 . Three Factor Eating Questionnaire ( TFEQ ) - measure restraint , disinhibition hunger ( Stunkard &amp; Messick . J Psychosom Res 29:7183 , 1985 ) ( Appendix 6 ) . 8 . Barratt Impulsiveness Scale measure impulsivity link overeating ( Patton JM et al J Clin Psych 51 : 76874 , 1995; Yeomans MR et al . Appetite . 50:46976 , 2008 ) ( Appendix 7 ) . 9 . PANAS - questionnaire measure positive negative affect ( Watson , Clark &amp; Tellegen . J Pers Soc Psych 54 ( 6 ) : 10631070 , 1988 ) ( Appendix 8 ) . 10 . Fagerstrom Test Nicotine Dependence - questionnaire assess current smoking behaviour ( Heatherton et al . British Journal Addiction 86 : 1119-1127 , 1991 ) ( Appendix 9 ) . 11 . Impact Weight Quality Life Questionnaire ( IWQOLLite ) - questionnaire measure change subjective quality life bariatric surgery ( Kolotkin et al . Obesity Research 9 : 102111 , 2001 ) ( Appendix 10 ) . 12 . SF-36 - ass health individual patient , evaluate cost-effectiveness treatment monitor compare disease burden ( McHorney Ware , 1995 ) ( Appendix 11 ) . 13 . Hospital Anxiety Depression Scale - indentify psychiatric disorder depression ( Spinhoven et al. , 1997 ) ( Appendix 12 ) . 14 . AUDIT drug alcohol questionnaire ( pick early sign hazardous harmful drinking identify mild dependence ( Saunders et al. , 1993 ) ( Appendix 13 ) . SALIVA SAMPLING Saliva sample collect use Oragene DNA vial . The acquisition saliva sample do accordingly manufacturer 's instruction . The patient eat , drink , smoke chew gum 30 minute give saliva sample . The patient spit container amount liquid saliva ( bubble ) reach least level show manufacturer 's instruction . The member staff put container flat surface , screws cap onto container need make sure cap close tightly . The container mixed gently least 10 second keep room temperature . BLOOD SAMPLING At study visit 1-7 , venous blood sample take . No 100 ml blood take participant entire study ( 15 mls visit ) . Standard method use obtain DNA , RNA serum blood . Plasma level glucose , insulin C-peptide measure immunoassay . URINE AND FAECES SAMPLING Urine faeces collect metabolomic analysis 10ml 20ml Sterilin container patient . faeces sample collect sterile container contain 10 mL phosphate buffer saline ( PBS ) ( contain , per liter , 8 g NaCl , 0.2 g KCl , 1.44 g Na2HPO4 , 0.24 g KH2PO4 [ pH 7.2 ] ) store home freezer bring laboratory sample store −80°C processing . TISSUE SAMPLING DURING SURGERY All biopsies take scissors and/or Harmonic scalpel ( ultrasound instrument dissection ) . Muscle tissue take abdominal wall troachar site . Liver tissue take edge leave liver lobe via needle biopsy . Subcutaneous fat tissue take incision troachar ( 2 g ) visceral fat tissue take major omentum great curvature stomach . This do time surgery , patient require re-operation . Standard method use store tissue stabilize purify DNA RNA tissue purpose study .</detailed_description>
	<mesh_term>Obesity</mesh_term>
	<mesh_term>Obesity , Morbid</mesh_term>
	<criteria>BMI &gt; 28 kg/m2 Age 1865 year donation blood within last 3 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>diabetes</keyword>
	<keyword>diabetes remission</keyword>
	<keyword>obesity</keyword>
	<keyword>bariatric surgery</keyword>
	<keyword>gene expression</keyword>
	<keyword>genetic variation</keyword>
	<keyword>metabolomics</keyword>
	<keyword>metabonomics</keyword>
	<keyword>epigenetic variation</keyword>
	<keyword>mutation</keyword>
</DOC>